Big leaps in science are presenting parents with choices that were once impossible — screening the DNA of embryos to help pick a future child with lower risks of disease, and higher odds of being taller or even smarter. But with the new technology comes a renewed ethical debate. Tony Dokoupil spoke to Nucleus Genomics CEO Kian Sadeghi.
Want more insights? Join Grow With Caliber - our career elevating newsletter and get our take on the future of work delivered weekly.
